These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6719401)

  • 1. Platelet factor 3 assay and the availability of platelet factor 3 in collagen or thrombin stimulated platelets.
    Brox JH; Osterud B
    Thromb Res; 1984 Mar; 33(5):555. PubMed ID: 6719401
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence for appearance of "lysis independent" procoagulant activities in collagen or thrombin stimulated platelets.
    Brox JH; Osterud B
    Thromb Res; 1983 Jun; 30(5):449-58. PubMed ID: 6612678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the procoagulant activity of platelets stimulated by collagen and thrombin.
    Bevers EM; Comfurius P; Hemker HC; Zwaal RF
    Thromb Res; 1984 Mar; 33(5):553-4. PubMed ID: 6719400
    [No Abstract]   [Full Text] [Related]  

  • 4. Determination of platelet factor 3 by thrombin generation using a micro-coagulation assay.
    Kirchhof B; Balleisen L
    Thromb Res; 1982 Aug; 27(3):303-10. PubMed ID: 6890246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phospholipids and platelet procoagulant activity in myeloproliferative syndromes].
    Martínez E; César J; Navarro JL; Mercado A; Pardo A; García Avello A; García Frade J
    Sangre (Barc); 1985; 30(1):22-7. PubMed ID: 4039850
    [No Abstract]   [Full Text] [Related]  

  • 6. Absent plasma second phase platelet aggregation factor in a patient with Hageman trait.
    Okonkwo P; Post R; Sise H
    Thromb Diath Haemorrh; 1970 Jun; 23(3):423-31. PubMed ID: 5432187
    [No Abstract]   [Full Text] [Related]  

  • 7. [Multimeric structure of factor VIII/von Willebrand factor released from human platelets by ADP, collagen and thrombin].
    López Fernández MF; Batlle Fonrodona FJ; Ginsberg MH; Ruggeri ZM; Zimmerman TS
    Sangre (Barc); 1983; 28(4):439-49. PubMed ID: 6419355
    [No Abstract]   [Full Text] [Related]  

  • 8. Expression of coagulant activity in human platelets: release of membranous vesicles providing platelet factor 1 and platelet factor 3.
    Sandberg H; Bode AP; Dombrose FA; Hoechli M; Lentz BR
    Thromb Res; 1985 Jul; 39(1):63-79. PubMed ID: 3839944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibition of primary hemostasis and the coagulative pathway].
    Di Micco B; Cinque MR; Pagliara E; Ciccone S; Messina MF; De Felice MG; Del Guercio R; Marcacci M
    Pediatria (Napoli); 1979 Jun; 87(2):219-26. PubMed ID: 44903
    [No Abstract]   [Full Text] [Related]  

  • 10. Protease-activated receptor 1 is the primary mediator of thrombin-stimulated platelet procoagulant activity.
    Andersen H; Greenberg DL; Fujikawa K; Xu W; Chung DW; Davie EW
    Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11189-93. PubMed ID: 10500152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of human plasma lipoproteins on platelet aggregation and platelet factor 3 activity in vitro.
    Miller NE; Nordoy A
    Atherosclerosis; 1977 Oct; 28(2):181-6. PubMed ID: 199206
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunoassay of human platelet factor 4(PF4, antiheparin factor) by radial immunodiffusion.
    Niewiarowski S; Lowery CT; Hawiger J; Millman M; Timmons S
    J Lab Clin Med; 1976 Apr; 87(4):720-33. PubMed ID: 818325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased platelet aggregation, Ca2+ and Mg2+ ATPase and platelet factor 3 activities in patients with Wilson disease.
    Cohen AM; Brettbart H; Creter D; Levinsky H; Frydman M; Djaldetti M
    Haematologica; 1984; 69(3):263-71. PubMed ID: 6147299
    [No Abstract]   [Full Text] [Related]  

  • 14. [Liberation of platelet factor 4 during the platelet aggregation induced by ADP, thrombin and collagen fibres (author's transl)].
    Domingo-Albós A; Doménech-Mateu D; Castillo-Cofiño R
    Rev Esp Fisiol; 1973 Mar; 29(1):11-5. PubMed ID: 4749041
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative effects of phenylbutazone, naproxen and flunixin meglumine on equine platelet aggregation and platelet factor 3 availability in vitro.
    Johnstone IB
    Can J Comp Med; 1983 Apr; 47(2):172-9. PubMed ID: 6883184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and biochemical characteristics of a primary platelet disorder.
    Sahud MA
    Acta Univ Carol Med Monogr; 1972; 53():317-24. PubMed ID: 4670738
    [No Abstract]   [Full Text] [Related]  

  • 17. Association of factor V activity with membranous vesicles released from human platelets: requirement for platelet stimulation.
    Bode AP; Sandberg H; Dombrose FA; Lentz BR
    Thromb Res; 1985 Jul; 39(1):49-61. PubMed ID: 3839943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The platelet membrane as a catalytic surface in thrombin generation: availability of platelet factor 1 and platelet factor 3.
    Bode AP; Dombrose FA; Lentz BR; Roberts HR
    Ann N Y Acad Sci; 1981; 370():348-58. PubMed ID: 6943964
    [No Abstract]   [Full Text] [Related]  

  • 20. Collagen derived octapeptide inhibits platelet procoagulant activity induced by the combined action of collagen and thrombin.
    Bevers EM; Karniguian A; Legrand YJ; Zwaal RF
    Thromb Res; 1985 Feb; 37(3):365-70. PubMed ID: 3922080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.